https://www.healthcentral.com/article/new-medication-available-for-people-who-have-moderate-to-severe-copd
Health A-Z
Ask a question
Health Central
    • Healthy Living
      • Food & Nutrition
      • Fitness & Exercise
      • Children's Health
      • Men's Health
      • Women's Health
      • Healthy Aging
    • Resources
      • Encyclopedia
      • News
      • Newsletters
  • Health Conditions & Topics
    • ADHD
    • Allergies
    • Alzheimer's Disease
    • Arthritis & Joints
    • Asthma
    • Bipolar Disorder
    • Brain & Nerve Health
    • COPD
    • Crohn's Disease
    • Dementia
    • Dental Health
    • Depression
    • Diabetes
    • Digestive Health
    • Erectile Dysfunction
    • GERD
    • Health Care & Insurance
    • Heart Health
    • Hepatitis C
    • High Cholesterol
    • Incontinence
    • Infectious Diseases
    • Lung & Respiratory
    • Menopause
    • Mental Health
    • Migraine
    • Multiple Sclerosis
    • Obesity
    • Pain Management
    • Pregnancy & Fertility
    • Prostate Health
    • Psoriasis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Skin Health
    • Sexual Health
    • Sleep Disorders
    • Thyroid Health
    • Ulcerative Colitis
    • Vision Health
  • Cancer Care
    • Cancer
    • Brain Cancer
    • Breast Cancer
    • Colon Cancer
    • Lung Cancer
    • Multiple Myeloma
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Stomach Cancer

COPD

Also See Lung Cancer | Asthma | Diabetes | Heart Health
Get Our Newsletters Share Your Story
Kathi  MacNaughton

New Medication Available for People Who Have Moderate to Severe COPD

Kathi MacNaughton / @kathihealth , Health Professional

Recently, a brand new medication was approved for use in the United States by the Food & Drug Administration (FDA, for short). The drug’s chemical name is Roflumilast, but is being marketed under the name Daliresp by New York City-based Forest Laboratories. It is specifically designed for people with severe COPD associated with chronic bronchitis and a history of exacerbations.

More than 12 million people in the United States have been diagnosed with COPD. Approximately one-third of people who have COPD, or 4 million, have severe disease. And almost three-quarters, or 2.8 million, of those with severe COPD also have chronic bronchitis.

How it Works

Daliresp blocks an inflammation-causing enzyme called phosphodiesterase type 4 (called PDE4 for short). People who have COPD tend to have way too much of this enzyme in their bodies. Left unchecked, PDE4 can result in a blockage of the airways.

Daliresp is NOT a steroid or a bronchodilator, though, and should never be used to treat acute bronchial spasms or shortness of breath “attacks”. It is meant to be used, as prescribed, on a regular, ongoing basis.

It is an oral medication (pill) that is taken once daily.

Who Should Take It

Your personal physician will make the ultimate decision on whether Daliresp is the right choice for you, but in general, this new medication is designed to help people severe levels of COPD avoid further exacerbations, or flares.

Studies have shown that it is effective in preventing flares and complications such as chronic bronchitis. It has been proven to reduce the frequency of flares by as much as 17 percent.

It should not be used to treat the onset of sudden breathing problems, nor is it recommended for people younger than age 18. It also should not be taken by people who have liver impairment (but that is true of most drugs, as the liver is involved in breaking down medications).

Possible Side Effects

However, like most drugs, Daliresp can have side effects. The safety of Daliresp was measured in eight different clinical trials with 4,425 people who took the medication. Less than 10 percent of the study participants experienced side effects.

These are the known common side effects for Daliresp:

  • Diarrhea
  • Nausea
  • Headache
  • Insomnia
  • Back pain
  • Loss of appetite
  • Dizziness

Less common, but more serious side effects may include changes in mood, thinking or behavior, and unexpected weight loss. Often side effects from drugs will subside over time as your body gets used to this new chemical. But any time you have an unexpected or undesirable effect from a medication, it’s wise to call the doctor to discuss whether you should continue with it.

Availability

Daliresp should be available now or within a short time, as Forest Laboratories estimated its release in the second quarter of 2011, which began April 1st.

In Summary

Daliresp is the only PDE4-inhibitor available today, so it offers significant promise in the treatment of COPD over existing therapies. If you are looking to enhance your COPD treatment, you may want to discuss Daliresp with your doctor next time you go in for an office visit.

Kathi is an experienced consumer health education writer, with a prior career in nursing that spanned more than 30 years — much of it in the field of home health care. Over the past 15 years, she’s been an avid contributor for a number of consumer health websites, specializing in asthma, allergy, and COPD. She writes not only as a healthcare professional, but also as a lifelong sufferer of severe allergies and mild asthma, and as a caregiver for her mother with COPD.

Published On: April 4, 2011
6 Ways to Avoid Lung Infections
6 Ways to Avoid Lung Infections
Dealing with a COPD Flare Up Dealing with a COPD Flare Up
Keeping Airways Clear with COPD
The Serious Implications for Kids Who Smoke

© 2018 Remedy Health Media, LLC All rights reserved

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Security Policy
  • Advertise With Us
  • Our Sites
  • The Body
  • The Body Pro
  • Berkeley Wellness
  • Health Communities
  • Intelecare
  • Mood 24/7